Announced
Completed
Synopsis
Adare Pharmaceuticals, a clinical-stage pharmaceutical company, completed the acquisition of Orbis Biosciences, a pharmaceutical technology company. Financial terms were not disclosed. "The acquisition by Adare will globalize the reach of our technologies and services. Orbis’s focus on precision delivery solutions has enabled us to develop expertise in novel extended-release and pulsatile-release formulations and to collaborate with great partners. We are pleased to join Adare, an industry leader in drug formulation development and manufacturing," Maria Flynn, Orbis Biosciences President and CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.